StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Saturday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of BTX opened at $2.18 on Friday. The business’s 50 day simple moving average is $2.55 and its 200-day simple moving […]